How to Avoid False Profits

By
A A A

By George R. Evans, CFA, Chief Investment Officer, Equities

Recently, I've seen significant under-performance from “quality” stocks in non-U.S. developed markets. This is not surprising. New entrants who come into markets after a rally are nearly always afraid they have “missed it,” so rather than focusing on future long-term gains, they often respond by trying to find “bargains” that can yield a short-term payoff. Usually, this may involve buying companies that are highly levered into good macroeconomic news and that will pop more than will steady earners as that news comes through.

I’ve seen this phenomenon in Europe particularly, where in tandem with September headlines trumpeting “U.S. Investors Pile into European Equities,”1 the share prices of many companies with strong global franchises actually declined. This was especially the case with those who earn a significant portion of their revenues in emerging markets: consumer staples firms such as Nestlé (NSRGY), Unilever (UN), Danone (DANOY), Diageo (DEO), Pernod Ricard (PDRDY), SABMiller (SBMRY) and Heineken (HEINY). Concerns over a potential near-term slowdown in emerging market growth produced the sort of binary overreaction that markets so often display: investors sold companies at valuations half-or less than half-of what their emerging market subsidiaries were trading.

In my opinion, focusing on the short term is tantamount to chasing the market. Trying to predict news flow and second-guess the reactions of other market participants is a good way to always be a step behind. Investors are better served by working to understand the potential long-term value of companies by looking for strong businesses that may create portfolio value for years to come. The companies to whom it makes sense to allocate capital include ones with good fundamentals, such as hard-to-replicate brands, strong market positions, effective business models, durable pricing power, consistently positive returns on invested capital and the financial flexibility of a strong balance sheet.

I actually agree that investors should be buying European equities. On a long term-view, good quality companies in Europe are modestly valued. With broad multiples at levels where we believe the market is assigning little value to “quality companies,” opportunities abound for patient, active managers who concentrate on fundamentals.

1 Source: Financial Times, 9/8/13.

The original commentary is available at OppenheimerFunds.com.

As of September 30, 2013, Oppenheimer International Growth Fund had 1.01% of its assets invested in Unilever; 1.01% of its assets invested in Danone; 1.23% of its assets invested in Diageo; 1.16% of its assets invested in Pernod Ricard; and 1.34% of its assets invested in Heineken.

The mention of specific companies does not constitute a recommendation by any particular fund or by OppenheimerFunds.

Past performance does not guarantee future results.

Foreign investments may be volatile and involve additional expenses and special risks, including currency fluctuations, foreign taxes and geopolitical risks. Emerging and developing market investments may be especially volatile. Due to the recent global economic crisis that caused financial difficulties for many European Union countries, Eurozone investments may be subject to volatility and liquidity issues. Investments in securities of growth companies may be volatile. Small and mid-sized company stock is typically more volatile than that of larger, more established businesses, as these stocks tend to be more sensitive to changes in earnings expectations. It may take a substantial period of time to realize a gain on an investment in a small or mid-sized company, if any gain is realized at all. Diversification does not guarantee profit or protect against loss.

Mutual funds are subject to market risk and volatility. Shares may gain or lose value.

 

These views represent the opinions of OppenheimerFunds and are not intended as investment advice or to predict or depict performance of any investment. These views are as of the open of business on November 13, 2013, and are subject to change based on subsequent developments.

Carefully consider fund investment objectives, risks, charges and expenses. Visit oppenheimerfunds.com, call your advisor or 1.800.225.5677 (CALL-OPP) for a prospectus with this and other fund information. Read it carefully before investing.

Oppenheimer funds are distributed by OppenheimerFunds Distributor, Inc. Oppenheimer funds are distributed by OppenheimerFunds Distributor, Inc. OppenheimerFunds Distributor, Inc. is not affiliated with The NASDAQ OMX Group, Inc..
© 2013 OppenheimerFunds Distributor, Inc. All rights reserved.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Stocks , Business , Investing Ideas

Referenced Stocks: DEO , UN

OppenheimerFunds


More from OppenheimerFunds:

Related Videos

Stocks

Referenced

100%
100%

Most Active by Volume

48,099,947
  • $16.09 ▲ 0.50%
40,277,806
  • $102.50 ▲ 0.24%
40,236,499
  • $19.57 ▲ 2.35%
31,092,510
  • $49.75 ▲ 0.65%
30,795,218
  • $34.92 ▲ 0.78%
29,910,855
  • $3.63 ▲ 0.83%
24,019,154
  • $13.06 ▼ 0.38%
23,753,906
  • $74.82 ▲ 1.31%
As of 8/29/2014, 04:04 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com